{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:10:29Z","timestamp":1760605829691,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.coi.2013.07.012","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T08:45:17Z","timestamp":1377247517000},"page":"775-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["T cell recognition of beryllium"],"prefix":"10.1016","volume":"25","author":[{"given":"Shaodong","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T","family":"Falta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie A","family":"Bowerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P","family":"Fontenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2013.07.012_sbref0005","doi-asserted-by":"crossref","first-page":"18517","DOI":"10.1073\/pnas.1215928109","article-title":"T-cell receptor (TCR) interaction with peptides that mimic nickel offers insight into nickel contact allergy","volume":"109","author":"Yin","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2013.07.012_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00043764-198907000-00011","article-title":"Screening blood test identifies subclinical beryllium disease","volume":"31","author":"Kreiss","year":"1989","journal-title":"J Occup Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0015","first-page":"267","article-title":"Beryllium disease screening in the ceramics industry: blood test performance and exposure-disease relations","volume":"35","author":"Kreiss","year":"1993","journal-title":"J Occup Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0020","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","article-title":"Epidemiology of beryllium sensitization and disease in nuclear workers","volume":"148","author":"Kreiss","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.coi.2013.07.012_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2\u03bcg\/m3","volume":"30","author":"Kreiss","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004200100237","article-title":"Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant","volume":"74","author":"Henneberger","year":"2001","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.coi.2013.07.012_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk","volume":"171","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0040","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history","volume":"139","author":"Newman","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.coi.2013.07.012_bib0045","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/ajrccm\/145.5.1212","article-title":"Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferation response to beryllium","volume":"145","author":"Newman","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.coi.2013.07.012_bib0050","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jcp.39.8.900","article-title":"New aid for diagnosing chronic beryllium disease (CBD): laser ion mass analysis (LIMA)","volume":"39","author":"Jones-Williams","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.coi.2013.07.012_bib0060","first-page":"111","article-title":"Laser microprobe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis, and other granulomatous diseases","volume":"6","author":"Jones-Williams","year":"1989","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.coi.2013.07.012_bib0065","first-page":"937S","article-title":"The natural history of beryllium sensitization and chronic beryllium disease","volume":"104","author":"Newman","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.coi.2013.07.012_bib0070","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI0215846","article-title":"Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease","volume":"110","author":"Fontenot","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2013.07.012_bib0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-\u03b3 in berylliosis","volume":"158","author":"Tinkle","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0085","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI24908","article-title":"Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response","volume":"115","author":"Fontenot","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2013.07.012_bib0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1172\/JCI200318317","article-title":"CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells","volume":"112","author":"Fontenot","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2013.07.012_bib0095","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM198904273201702","article-title":"Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells","volume":"320","author":"Saltini","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.coi.2013.07.012_bib0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","article-title":"Interaction of genetic and exposure factors in the prevalence of berylliosis","volume":"32","author":"Richeldi","year":"1997","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0110","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0115","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0120","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajim.20045","article-title":"The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization","volume":"46","author":"McCanlies","year":"2004","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0130","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.4049\/jimmunol.1200798","article-title":"Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove","volume":"189","author":"Silveira","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/oem.2010.055046","article-title":"HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity","volume":"68","author":"Rosenman","year":"2011","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.coi.2013.07.012_sbref0140","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1073\/pnas.1001772107","article-title":"Crystal structure of HLA-DP2: Implications for chronic beryllium disease","volume":"107","author":"Dai","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2013.07.012_bib0145","doi-asserted-by":"crossref","first-page":"e2403","DOI":"10.1371\/journal.pone.0002403","article-title":"Model for the peptide-free conformation of class II MHC proteins","volume":"3","author":"Painter","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2013.07.012_bib0150","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20011971","article-title":"Structural basis of cytochrome c presentation by IE(k)","volume":"195","author":"Fremont","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1074-7613(00)80220-4","article-title":"Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice","volume":"12","author":"Latek","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2013.07.012_bib0160","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1073\/pnas.131213698","article-title":"BeF3\u2212 acts as a phosphate analog in proteins phosphorylated on aspartate: structure of a BeF3\u2212 complex with phosphoserine phosphatase","volume":"98","author":"Cho","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2013.07.012_bib0165","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2013.07.012_bib0170","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.166.5.3549","article-title":"HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease","volume":"166","author":"Lombardi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-0039.1998.tb02946.x","article-title":"Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes","volume":"51","author":"Gilchrist","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.coi.2013.07.012_bib0180","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.4049\/jimmunol.175.10.7029","article-title":"Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II \u03b2-chain","volume":"175","author":"Bill","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20100725","article-title":"A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC","volume":"208","author":"Sethi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ni1187","article-title":"Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor","volume":"6","author":"Hahn","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0195","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/sj.emboj.7600771","article-title":"Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2013.07.012_sbref0200","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.4049\/jimmunol.1101872","article-title":"Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition","volume":"187","author":"Bowerman","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0205","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00251-004-0735-5","article-title":"Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs","volume":"56","author":"Diaz","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.coi.2013.07.012_sbref0210","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.20122426","article-title":"Identification of peptides recognized by CD4 T cells in chronic beryllium disease","volume":"210","author":"Falta","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2013.07.012_bib0215","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.0903655","article-title":"Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity","volume":"184","author":"Sidney","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2013.07.012_bib0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13238-012-2108-4","article-title":"Immune plexins and semaphorins: old proteins, new immune functions","volume":"4","author":"Roney","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.coi.2013.07.012_bib0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1101\/cshperspect.a007765","article-title":"Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?","volume":"2","author":"Marrack","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coi.2013.07.012_sbref0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791513001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791513001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:30:14Z","timestamp":1760603414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791513001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0952791513001271"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2013.07.012","relation":{},"ISSN":["0952-7915"],"issn-type":[{"type":"print","value":"0952-7915"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell recognition of beryllium","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2013.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}